Ajax-Loading

Novavax Inc - Retained Earnings

Novavax Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Retained-Earnings" stands at -4.59 Billion United States Dollars as of 09/30/2025.

As of the end of Novavax Inc's third quarter, the item "Retained Earnings" stands at -4.59 Billion USD. This represents a decrease of -4.62 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.3417 Billion United States Dollars compared to the value the year prior.
The 1 year change is 0.3417 Billion United States Dollars.
The 3 year change is -0.492 Billion United States Dollars.
The 5 year change is -2.89 Billion United States Dollars.
The 10 year change is -4.01 Billion United States Dollars.

The Serie's long term average value is -1.86 Billion United States Dollars. It's latest available value, on 09/30/2025, is -2.73 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2024, to it's latest available value, on 09/30/2025, is +0.4228 Billion.
The Serie's change in United States Dollars from it's maximum value, on 12/31/2010, to it's latest available value, on 09/30/2025, is -4.28 Billion.

Retained Earnings for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Retained Earnings905,699,262,464.00
LogoJohnson & Johnson - Retained Earnings486,508,953,600.00
LogoAbbVie Inc - Retained Earnings399,570,305,024.00
LogoRoche Holding AG - Retained Earnings317,433,206,677.55
LogoAstraZeneca PLC - Retained Earnings280,205,508,085.11